Karimi, Elham
Khorvash, Fariborz
Arab, Arman
Sepidarkish, Mahdi
Saadatnia, Mohammad
Amani, Reza
Funding for this research was provided by:
Isfahan University of Medical Sciences (3400461)
Article History
Received: 5 November 2022
Accepted: 8 February 2023
First Online: 16 February 2023
Declarations
:
: The protocol of the current study was approved by the Research Ethics Committee of Isfahan University of Medical Sciences (approval number: IR.MUI.RESEARCH.REC.1400.291; approval date: 9 October 2021) and also was registered at the Iranian Registry of Clinical Trials (registration number: IRCT20180818040827N4; registration date: 16 October 2021). This study will be conducted according to the principles of the Declaration of Helsinki. Before the participants’ enrollment, an explanation will be provided to them by the researcher (E.K) regarding the informed consent contents, study procedures, objectives, and potential outcomes and their participation are voluntary. All of the enrolled patients should provide an informed written consent form. In cases where the patient is unable to sign a consent form, his/her legal guardian writes informed consent. All data are handled with strict confidentiality, assuring the anonymity of patients.
: Not applicable.
: The authors declare no competing interests.